When mRNA (messenger RNA) vaccines are injected into a patient, tiny lipid vesicles transport mRNA molecules through the body fluids and merge with immune cells, called antigen-presenting cells (APCs). mRNA vaccines work to instruct APCs to manufacture proteins called antigens that evoke an immune response to the threat.
Related CAS Insights
Drug Discovery
Accelerating discovery: COVID-19 vaccine breakthroughs and their future impact
Drug Discovery
Accelerating Discovery: COVID-19 Vaccine Breakthroughs and their Future Impact
Drug Discovery
ACE2: Targeting a potentially important receptor in disease pathogenesis
Gain new perspectives for faster progress directly to your inbox.
